Doctors review past cases to gauge leukemia Drug's Real-World impact
NCT ID NCT07356960
Summary
This study looks back at the medical records of about 100 adults with a specific type of leukemia (Philadelphia-positive ALL) who were already treated with the drug ponatinib as part of their regular care. The goal is to see how effective the treatment was in a real-world setting, outside of a formal clinical trial, by checking how many patients achieved a deep level of remission. Researchers are not giving any new treatment; they are only analyzing past patient data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBKASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.